CRSP
HealthcareCRISPR Therapeutics AG
$48.62-0.25 (-0.52%)
Prev Close
$48.87
Open
$49.70
High
$50.07
Low
$47.53
Volume
1.59M
Market Cap
$5.56B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at CRISPR Therapeutics AG (CRSP) has been dominated by buying, with 3 insider purchases totaling $52.69M and 16 insider sales totaling $15.67M. The most recent insider transaction was by KASINGER JAMES R. (General Counsel and Secretary), who sold $111.0K worth of shares on Feb 18, 2026. CRISPR Therapeutics AG operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $5.56B.
Buys (12M)
3
$52.69M
Sells (12M)
16
$15.67M
Net Activity
Net Buyer
$37.02M
Active Insiders
8
last 12 mo
CRSP Price Chart
CRSP Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,112 | $52.58 | $111.0K | 0 |
| Feb 18, 2026↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 6,967 | $52.58 | $366.3K | 0 |
| Jan 22, 2026↗ | Prasad Raju | Chief Financial Officer | Sell | 34,972 | $60.19 | $2.10M | 0 |
| Jan 20, 2026↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 90,000 | $57.40 | $5.17M | 0 |
| Jan 6, 2026↗ | Prasad Raju | Chief Financial Officer | Sell | 29,700 | $60.16 | $1.79M | 0 |
| Dec 22, 2025↗ | Prasad Raju | Chief Financial Officer | Sell | 10,000 | $55.95 | $559.5K | 0 |
| Oct 16, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 50,895 | $67.91 | $3.46M | 0 |
| Oct 13, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,076 | $66.60 | $71.7K | 0 |
| Oct 13, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 4,242 | $66.60 | $282.5K | 0 |
| Aug 16, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 13,081 | $58.15 | $760.7K | 0 |
| Aug 6, 2025↗ | Treco Douglas A | Director | Buy | 20,000 | $57.03 | $1.14M | 0 |
| Jul 16, 2025↗ | George Simeon | Director | Buy | 989,812 | $52.03 | $51.50M | 0 |
| May 28, 2025↗ | Patel Naimish | Chief Medical Officer | Sell | 3,932 | $35.94 | $141.3K | 0 |
| Apr 3, 2025↗ | Patel Naimish | Chief Medical Officer | Buy | 1,508 | $32.96 | $49.7K | 0 |
| Mar 20, 2025↗ | Bruno Julianne | Chief Operating Officer | Sell | 1,714 | $41.23 | $70.7K | 0 |
| Mar 20, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,185 | $41.23 | $131.3K | 0 |
| Mar 20, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 10,031 | $41.23 | $413.6K | 0 |
| Mar 20, 2025↗ | Prasad Raju | Chief Financial Officer | Sell | 2,197 | $41.23 | $90.6K | 0 |
| Mar 14, 2025↗ | Prasad Raju | Chief Financial Officer | Sell | 3,762 | $41.80 | $157.3K | 0 |
| Mar 10, 2025↗ | Bruno Julianne | Chief Operating Officer | Sell | 1,388 | $42.54 | $59.0K | 0 |
| Mar 10, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,966 | $42.67 | $169.2K | 0 |
| Mar 10, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 14,435 | $42.70 | $616.3K | 0 |
| Feb 26, 2025↗ | Greene John | Director | Buy | 7,000 | $44.85 | $313.9K | 0 |
| Feb 19, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 18,360 | $55.20 | $1.01M | 0 |
| Feb 18, 2025↗ | Bruno Julianne | Chief Operating Officer | Sell | 333 | $52.80 | $17.6K | 0 |
| Feb 18, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 18,568 | $54.21 | $1.01M | 0 |
| Feb 16, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 11,542 | $53.67 | $619.5K | 0 |
| Dec 2, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 15,000 | $55.10 | $826.6K | 0 |
| Nov 11, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $55.62 | $1.67M | 0 |
| Oct 13, 2024↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,089 | $46.28 | $50.4K | 0 |
| Oct 13, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 4,293 | $46.28 | $198.7K | 0 |
| Jun 20, 2024↗ | Bruno Julianne | Chief Operating Officer | Sell | 3,366 | $56.09 | $188.8K | 0 |
| Apr 15, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 19,582 | $59.91 | $1.17M | 0 |
| Mar 15, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $72.48 | $1.45M | 0 |
| Mar 14, 2024↗ | Prasad Raju | Chief Financial Officer | Sell | 3,524 | $72.69 | $256.2K | 0 |
| Mar 10, 2024↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,947 | $77.15 | $304.5K | 0 |
| Mar 10, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 14,385 | $77.04 | $1.11M | 0 |
| Feb 18, 2024↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,913 | $79.67 | $152.4K | 0 |
| Feb 18, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 6,370 | $79.67 | $507.5K | 0 |
| Feb 15, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $80.36 | $1.61M | 0 |
| Jan 29, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 50,000 | $60.51 | $3.03M | 0 |
| Jan 16, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $62.50 | $1.25M | 0 |
| May 30, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $64.88 | $1.62M | 0 |
| May 23, 2023↗ | Morrow Phuong Khanh | Chief Medical Officer | Sell | 2,527 | $65.91 | $166.6K | 0 |
| Apr 25, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $50.67 | $1.27M | 0 |
| Mar 29, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $44.46 | $1.11M | 0 |
| Mar 10, 2023↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,305 | $43.22 | $99.6K | 0 |
| Mar 10, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 9,444 | $43.22 | $408.2K | 0 |
| Feb 27, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $48.25 | $1.21M | 0 |
| Feb 18, 2023↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,950 | $48.26 | $94.1K | 0 |
| Feb 18, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 6,373 | $48.26 | $307.6K | 0 |
| Feb 18, 2023↗ | Smith Brendan | Chief Financial Officer | Sell | 1,392 | $48.26 | $67.2K | 0 |
| Jan 27, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $51.47 | $1.29M | 0 |
| Dec 28, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $40.93 | $1.02M | 0 |
| Dec 3, 2022↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,234 | $52.26 | $169.0K | 0 |
| Dec 3, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 19,401 | $52.26 | $1.01M | 0 |
| Nov 28, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $54.03 | $1.35M | 0 |
| Oct 26, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $54.81 | $1.37M | 0 |
| Oct 14, 2022↗ | Smith Brendan | Chief Financial Officer | Sell | 1,111 | $55.76 | $61.9K | 0 |
| Sep 28, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $64.61 | $1.62M | 0 |
| Aug 29, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $66.84 | $1.67M | 0 |
| Jul 27, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $75.91 | $1.90M | 0 |
| Jun 29, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $61.59 | $1.54M | 0 |
| Mar 10, 2022↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,360 | $61.91 | $146.1K | 0 |
| Mar 10, 2022↗ | Klein Lawrence Otto | CBO & COO | Sell | 3,112 | $61.98 | $192.9K | 0 |
| Mar 10, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 9,640 | $61.92 | $596.9K | 0 |
| Dec 3, 2021↗ | Ho Tony W | Executive VP, Head of R&D | Sell | 12,607 | $69.17 | $872.0K | 0 |
| Dec 3, 2021↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 6,303 | $69.17 | $436.0K | 0 |
| Dec 3, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 11,185 | $69.17 | $773.7K | 0 |
| Dec 3, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 37,818 | $69.17 | $2.62M | 0 |
| Dec 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 779 | $75.10 | $58.5K | 0 |
| Sep 10, 2021↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 4,741 | $117.86 | $558.8K | 0 |
| Sep 10, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 4,207 | $117.86 | $495.8K | 0 |
| Sep 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 787 | $124.83 | $98.2K | 0 |
| Aug 6, 2021↗ | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sell | 25,000 | $138.52 | $3.46M | 0 |
| Aug 4, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $128.78 | $3.86M | 0 |
| Jul 19, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 10,000 | $126.44 | $1.26M | 0 |
| Jun 30, 2021↗ | Novak Rodger | President | Sell | 25,000 | $165.00 | $4.13M | 0 |
| Jun 28, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 77,911 | $150.66 | $11.74M | 0 |
| Jun 28, 2021↗ | Novak Rodger | President | Sell | 25,000 | $156.55 | $3.91M | 0 |
| Jun 21, 2021↗ | Novak Rodger | President | Sell | 25,000 | $128.62 | $3.22M | 0 |
| Jun 15, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $126.43 | $3.79M | 0 |
| Jun 11, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 10,000 | $126.61 | $1.27M | 0 |
| Jun 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 779 | $115.80 | $90.2K | 0 |
| Mar 23, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 100,000 | $128.05 | $12.81M | 0 |
| Mar 22, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 30,374 | $132.37 | $4.02M | 0 |
| Mar 10, 2021↗ | Ho Tony W | Executive VP, Head of R&D | Sell | 2,141 | $124.15 | $265.8K | 0 |
| Mar 10, 2021↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,353 | $124.15 | $168.0K | 0 |
| Mar 10, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 2,141 | $124.15 | $265.8K | 0 |
| Mar 10, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 5,526 | $124.15 | $686.1K | 0 |
| Mar 10, 2021↗ | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sell | 1,352 | $124.15 | $167.9K | 0 |
| Mar 5, 2021↗ | Ho Tony W | Executive VP, Head of R&D | Sell | 1,585 | $114.65 | $181.7K | 0 |
| Mar 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 798 | $130.25 | $103.9K | 0 |
CRSP Insider Buying Activity
The following table shows recent insider purchases of CRISPR Therapeutics AG (CRSP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025↗ | Treco Douglas A | Director | Buy | 20,000 | $57.03 | $1.14M | 0 |
| Jul 16, 2025↗ | George Simeon | Director | Buy | 989,812 | $52.03 | $51.50M | 0 |
| Apr 3, 2025↗ | Patel Naimish | Chief Medical Officer | Buy | 1,508 | $32.96 | $49.7K | 0 |
| Feb 26, 2025↗ | Greene John | Director | Buy | 7,000 | $44.85 | $313.9K | 0 |
CRSP Insider Selling Activity
The following table shows recent insider sales of CRISPR Therapeutics AG (CRSP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,112 | $52.58 | $111.0K | 0 |
| Feb 18, 2026↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 6,967 | $52.58 | $366.3K | 0 |
| Jan 22, 2026↗ | Prasad Raju | Chief Financial Officer | Sell | 34,972 | $60.19 | $2.10M | 0 |
| Jan 20, 2026↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 90,000 | $57.40 | $5.17M | 0 |
| Jan 6, 2026↗ | Prasad Raju | Chief Financial Officer | Sell | 29,700 | $60.16 | $1.79M | 0 |
| Dec 22, 2025↗ | Prasad Raju | Chief Financial Officer | Sell | 10,000 | $55.95 | $559.5K | 0 |
| Oct 16, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 50,895 | $67.91 | $3.46M | 0 |
| Oct 13, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,076 | $66.60 | $71.7K | 0 |
| Oct 13, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 4,242 | $66.60 | $282.5K | 0 |
| Aug 16, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 13,081 | $58.15 | $760.7K | 0 |
| May 28, 2025↗ | Patel Naimish | Chief Medical Officer | Sell | 3,932 | $35.94 | $141.3K | 0 |
| Mar 20, 2025↗ | Bruno Julianne | Chief Operating Officer | Sell | 1,714 | $41.23 | $70.7K | 0 |
| Mar 20, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,185 | $41.23 | $131.3K | 0 |
| Mar 20, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 10,031 | $41.23 | $413.6K | 0 |
| Mar 20, 2025↗ | Prasad Raju | Chief Financial Officer | Sell | 2,197 | $41.23 | $90.6K | 0 |
| Mar 14, 2025↗ | Prasad Raju | Chief Financial Officer | Sell | 3,762 | $41.80 | $157.3K | 0 |
| Mar 10, 2025↗ | Bruno Julianne | Chief Operating Officer | Sell | 1,388 | $42.54 | $59.0K | 0 |
| Mar 10, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,966 | $42.67 | $169.2K | 0 |
| Mar 10, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 14,435 | $42.70 | $616.3K | 0 |
| Feb 19, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 18,360 | $55.20 | $1.01M | 0 |
| Feb 18, 2025↗ | Bruno Julianne | Chief Operating Officer | Sell | 333 | $52.80 | $17.6K | 0 |
| Feb 18, 2025↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 18,568 | $54.21 | $1.01M | 0 |
| Feb 16, 2025↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 11,542 | $53.67 | $619.5K | 0 |
| Dec 2, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 15,000 | $55.10 | $826.6K | 0 |
| Nov 11, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $55.62 | $1.67M | 0 |
| Oct 13, 2024↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,089 | $46.28 | $50.4K | 0 |
| Oct 13, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 4,293 | $46.28 | $198.7K | 0 |
| Jun 20, 2024↗ | Bruno Julianne | Chief Operating Officer | Sell | 3,366 | $56.09 | $188.8K | 0 |
| Apr 15, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 19,582 | $59.91 | $1.17M | 0 |
| Mar 15, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $72.48 | $1.45M | 0 |
| Mar 14, 2024↗ | Prasad Raju | Chief Financial Officer | Sell | 3,524 | $72.69 | $256.2K | 0 |
| Mar 10, 2024↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,947 | $77.15 | $304.5K | 0 |
| Mar 10, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 14,385 | $77.04 | $1.11M | 0 |
| Feb 18, 2024↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,913 | $79.67 | $152.4K | 0 |
| Feb 18, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 6,370 | $79.67 | $507.5K | 0 |
| Feb 15, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $80.36 | $1.61M | 0 |
| Jan 29, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 50,000 | $60.51 | $3.03M | 0 |
| Jan 16, 2024↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 20,000 | $62.50 | $1.25M | 0 |
| May 30, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $64.88 | $1.62M | 0 |
| May 23, 2023↗ | Morrow Phuong Khanh | Chief Medical Officer | Sell | 2,527 | $65.91 | $166.6K | 0 |
| Apr 25, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $50.67 | $1.27M | 0 |
| Mar 29, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $44.46 | $1.11M | 0 |
| Mar 10, 2023↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,305 | $43.22 | $99.6K | 0 |
| Mar 10, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 9,444 | $43.22 | $408.2K | 0 |
| Feb 27, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $48.25 | $1.21M | 0 |
| Feb 18, 2023↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,950 | $48.26 | $94.1K | 0 |
| Feb 18, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 6,373 | $48.26 | $307.6K | 0 |
| Feb 18, 2023↗ | Smith Brendan | Chief Financial Officer | Sell | 1,392 | $48.26 | $67.2K | 0 |
| Jan 27, 2023↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $51.47 | $1.29M | 0 |
| Dec 28, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $40.93 | $1.02M | 0 |
| Dec 3, 2022↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,234 | $52.26 | $169.0K | 0 |
| Dec 3, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 19,401 | $52.26 | $1.01M | 0 |
| Nov 28, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $54.03 | $1.35M | 0 |
| Oct 26, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $54.81 | $1.37M | 0 |
| Oct 14, 2022↗ | Smith Brendan | Chief Financial Officer | Sell | 1,111 | $55.76 | $61.9K | 0 |
| Sep 28, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $64.61 | $1.62M | 0 |
| Aug 29, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $66.84 | $1.67M | 0 |
| Jul 27, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $75.91 | $1.90M | 0 |
| Jun 29, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 25,000 | $61.59 | $1.54M | 0 |
| Mar 10, 2022↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,360 | $61.91 | $146.1K | 0 |
| Mar 10, 2022↗ | Klein Lawrence Otto | CBO & COO | Sell | 3,112 | $61.98 | $192.9K | 0 |
| Mar 10, 2022↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 9,640 | $61.92 | $596.9K | 0 |
| Dec 3, 2021↗ | Ho Tony W | Executive VP, Head of R&D | Sell | 12,607 | $69.17 | $872.0K | 0 |
| Dec 3, 2021↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 6,303 | $69.17 | $436.0K | 0 |
| Dec 3, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 11,185 | $69.17 | $773.7K | 0 |
| Dec 3, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 37,818 | $69.17 | $2.62M | 0 |
| Dec 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 779 | $75.10 | $58.5K | 0 |
| Sep 10, 2021↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 4,741 | $117.86 | $558.8K | 0 |
| Sep 10, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 4,207 | $117.86 | $495.8K | 0 |
| Sep 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 787 | $124.83 | $98.2K | 0 |
| Aug 6, 2021↗ | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sell | 25,000 | $138.52 | $3.46M | 0 |
| Aug 4, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $128.78 | $3.86M | 0 |
| Jul 19, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 10,000 | $126.44 | $1.26M | 0 |
| Jun 30, 2021↗ | Novak Rodger | President | Sell | 25,000 | $165.00 | $4.13M | 0 |
| Jun 28, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 77,911 | $150.66 | $11.74M | 0 |
| Jun 28, 2021↗ | Novak Rodger | President | Sell | 25,000 | $156.55 | $3.91M | 0 |
| Jun 21, 2021↗ | Novak Rodger | President | Sell | 25,000 | $128.62 | $3.22M | 0 |
| Jun 15, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 30,000 | $126.43 | $3.79M | 0 |
| Jun 11, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 10,000 | $126.61 | $1.27M | 0 |
| Jun 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 779 | $115.80 | $90.2K | 0 |
| Mar 23, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 100,000 | $128.05 | $12.81M | 0 |
| Mar 22, 2021↗ | Bolzon Bradley J PhD | Director | Sell | 30,374 | $132.37 | $4.02M | 0 |
| Mar 10, 2021↗ | Ho Tony W | Executive VP, Head of R&D | Sell | 2,141 | $124.15 | $265.8K | 0 |
| Mar 10, 2021↗ | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,353 | $124.15 | $168.0K | 0 |
| Mar 10, 2021↗ | Klein Lawrence Otto | CBO & COO | Sell | 2,141 | $124.15 | $265.8K | 0 |
| Mar 10, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 5,526 | $124.15 | $686.1K | 0 |
| Mar 10, 2021↗ | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sell | 1,352 | $124.15 | $167.9K | 0 |
| Mar 5, 2021↗ | Ho Tony W | Executive VP, Head of R&D | Sell | 1,585 | $114.65 | $181.7K | 0 |
| Mar 1, 2021↗ | Kulkarni Samarth | Chief Executive Officer | Sell | 798 | $130.25 | $103.9K | 0 |
CRSP Insiders
Similar Stocks to CRSP
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B